Facebook
X
LinkedIn
ForwardATLS 11 - Traditional 2 Day Course English (Non-CME)
ATLS 11 Student Course – Traditional
The Advanced Trauma Life Support® (ATLS®) course establishes an organized and systematic approach for evaluation and treatment of patients, promotes standards of care, and recognizes injury as a global healthcare challenge. The approach is easily remembered by any clinician, irrespective of practice specialty and experience, and can be rapidly recalled under the stress, anxiety, and intensity of the trauma resuscitation process. ATLS provides a common language for all clinicians that facilitates team and transfer communication.
The ATLS course emphasizes the application of new knowledge and skills. Instruction occurs in a variety of venues: self-study, small groups, and larger groups.
Application of didactic knowledge occurs through interactive discussions and online modules. Cognitive and psychomotor skills are introduced and practiced in the skills stations. Initial patient assessment stations provide opportunities to practice primary and secondary survey procedures.
For successful ATLS® Course completion, at minimum the learner is required to:
Complete all pre-course materials including a pretest and visualization of all videos. (Specific centers may have other pre-course requirements.)
For ATLS Hybrid courses, complete all modules prior to the in-person portion of the course. The timeframe for completion is determined by the center.
Attend the entire in-person portion of the course per the center’s schedule.
Actively participate in all interactive discussions.
Successfully perform all core psychomotor and cognitive skills as assessed by an ATLS instructor and / or course director.
Reach a passing grade on a multiple-choice examination.
Perform at an adequate level on an evaluation initial assessment scenario simulation as determined by an ATLS instructor and / or course director.
Demonstrate appropriate skills, knowledge, and attitudes throughout the ATLS course.
Demonstrate appropriate professional conduct and fulfill any other requirements as described in the ATLS policy manual, other statements, or as determined by ATLS directors and offices.
Visit MyATLS App | ACS (facs.org), for more information and links to purchase the app.
Contact
For questions about course content, please contact the COT Trauma Education office at [email protected].
Target Audience
This activity is intended for health care clinicians involved in the evaluation and treatment of the injured patient, including:
Practicing physicians
Residents
Advanced practice clinicians
Medical students in their final year of study
Learning Objectives
Upon completing the ATLS® course, the participants will be able to:
Practice the concepts and principles of initial assessment through the primary and secondary patient surveys.
Establish management priorities in a simulated trauma situation.
Initiate primary and secondary management necessary for the emergency management of acute life-threatening conditions in a simulated patient.
Apply the key principles of effective team function and communication in a simulated trauma scenario.
Practice primary and secondary initial assessment surveys of a patient with simulated injuries.
Perform control of simulated life-threatening external hemorrhage.
Evaluate and manage airway patency and initiate assisted ventilation in a simulated trauma patient.
Demonstrate the procedure of surgical/incisional airway.
Identify clinical and radiographic signs of thoracic injuries.
Describe the steps for a needle or finger thoracostomy and chest tube insertion for pleural decompression in a simulated scenario.
Assess and treat a simulated patient in shock with recognition of life-threatening hemorrhage.
Perform intraosseous access in a simulated patient.
Apply an external pelvic compression device for hemorrhage due to pelvic fracture in a simulated trauma patient.
Evaluate the abdomen for hemorrhage with either peritoneal lavage or ultrasound (FAST).
Evaluate and treat a simulated patient with brain injury, including use of the Glasgow Coma Scale score.
Demonstrate protection of the spinal cord and radiographic and clinical evaluation of spine injuries in a simulated trauma scenario.
Perform musculoskeletal trauma assessment and management in a simulated scenario.
Apply the principles of trauma assessment of simulated older adults, pediatric patients, and pregnant patients.
In accordance with ACCME regulations (ACCME Standard 3), the American College of Surgeons must ensure that anyone who is able to control the content of the activity has disclosed all financial relationships with any ineligible companies in the 24 months prior to their involvement in the educational activity. There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to this education.
Ineligible Company: Companies that are ineligible to be accredited in the ACCME system (ineligible companies) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients. |
Financial Relationships: Financial relationships are relevant if the following three conditions are met for the individual who will control content of the education: 1) a financial relationship, in any amount, exists between the person in control of content and an ineligible company; 2) the financial relationship existed in the last 24 months; 3) the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. |
All CME Planners and Speakers /Moderators/Discussants/Authors/Editors involved in the development and/or presentation of CME content must complete this form. This form must be updated whenever circumstances require.
ATLS 11 Disclosures:
COT Leadership
Jeffrey D. Kerby, MD, PhD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Eileen M. Bulger, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
ATLS 11 Steering Committee
John P. Sutyak, EdM, MD, FACS, MAMSE
No relevant financial relationship(s) with ineligible companies to disclose
Dany Westerband, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Kimberly T. Joseph, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Sharon M. Henry, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
ATLS 11 Content Contributors
George S. Abi Saad, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Walid AbouGalala, MD, MSc
No relevant financial relationship(s) with ineligible companies to disclose
Sasha Adams, MD
No relevant financial relationship(s) with ineligible companies to disclose
Saud Al Turki, MBBS, PhD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Adnan A. Alseidi, MD, EdM, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Stanley Nnamdi Anyanwu, MBBS, FACS
No relevant financial relationship(s) with ineligible companies to disclose
John H. Armstrong, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Richard A. Bagdonas, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Andrew R. Baker, MBChB, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Liesl Baker, MbChB, FRCA
No relevant financial relationship(s) with ineligible companies to disclose
Abdullah Bakhsh, MBBS, FAAEM
No relevant financial relationship(s) with ineligible companies to disclose
Samir Ballouz, RN, Msc. IHM
No relevant financial relationship(s) with ineligible companies to disclose
Zsolt J. Balogh, MD, PhD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Robert Barraco, MD, MPH, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Sabrina Bawa, MD
No relevant financial relationship(s) with ineligible companies to disclose
Jonathan Begley, MBBS, MPH
No relevant financial relationship(s) with ineligible companies to disclose
Andrew C. Bernard, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Cherisse D. Berry, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Tasce Bongiovanni, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Stephanie Bonne, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
William Boyer, DHSc, MS
No relevant financial relationship(s) with ineligible companies to disclose
Nori Bradley, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Karen J. Brasel, MD, MPH, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Miloš Buhavac, MBBS, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jacqueline Bustraan, MSc
No relevant financial relationship(s) with ineligible companies to disclose
Claire Cain Leidy, BA
No relevant financial relationship(s) with ineligible companies to disclose
Carlos Julio Calderon Salazar, MD
No relevant financial relationship(s) with ineligible companies to disclose
Scott Cameron, MD, FACEM
No relevant financial relationship(s) with ineligible companies to disclose
Lisa Cannada, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jeannette M. Capella, MD, MEd, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Patricia Caplinger, MD, FACOG
No relevant financial relationship(s) with ineligible companies to disclose
Tatiana C.P. Cardenas, MD, MS, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Vicente Cardona-Infante, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Amanda M. Celii, MD
No relevant financial relationship(s) with ineligible companies to disclose
Allyson Chapman, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Theresa Chin, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Ian Civil, MBChB, FACS(Hon)
No relevant financial relationship(s) with ineligible companies to disclose
Audra Clark, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
James Colquitt, PhD, RRT-ACCS
No relevant financial relationship(s) with ineligible companies to disclose
Mary Condron, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mackenzie Cook, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Zara Cooper, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jaime Cortés-Ojeda, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Marie Crandall, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Alisa M. Cross, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Alfred Croteau, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Rafael Curado, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Arman Dagal, MD, MHA
No relevant financial relationship(s) with ineligible companies to disclose
Scott D’Amours, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Brian J. Daley, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Joao Carlos Das Neves Pereira, MD, PhD
No relevant financial relationship(s) with ineligible companies to disclose
Airton Leonardo de Oliveira Manoel, MD, PhD
No relevant financial relationship(s) with ineligible companies to disclose
Rochelle A. Dicker, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jody DiGiacomo, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Michael Dingeldein, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
John Donkersloot, MD
No relevant financial relationship(s) with ineligible companies to disclose
Alon Duby, MBBCh
No relevant financial relationship(s) with ineligible companies to disclose
Lauren M. Dudas, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Thomas K. Duncan, DO, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Julie A. Dunn, MD, MS, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Rick Dutton, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Wassim El-Habre, MBBCh
No relevant financial relationship(s) with ineligible companies to disclose
Paula Ferrada, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Joseph D. Forrester, MD, FACS
Dr. Forrester received funding from Varian for clinical trials; funding from Pacira for clinical trials; funding from Eclipse Regenysis for clinical trials; consulting fees from Costa Surgical Inc.
Paa Kobina Forson, MD, MPH
No relevant financial relationship(s) with ineligible companies to disclose
Claus-Robin Fritzemeier, D. Med
No relevant financial relationship(s) with ineligible companies to disclose
Alberto Garcia, MD, MSc
No relevant financial relationship(s) with ineligible companies to disclose
Diogo Garcia, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Subash Gautam, MBBS, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jaclyn Ann Gellings, MD
No relevant financial relationship(s) with ineligible companies to disclose
Lawrence M. Gillman, MD, MMedEd, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Agnieszka Gizzi, MA
No relevant financial relationship(s) with ineligible companies to disclose
James Gould, RN, NRP
No relevant financial relationship(s) with ineligible companies to disclose
Tristan Griffiths, MBBS, FACEM
No relevant financial relationship(s) with ineligible companies to disclose
Lucas L. Groves, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Tishia Gunton, MSW, LISW-S
No relevant financial relationship(s) with ineligible companies to disclose
Shailvi Gupta, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jennifer Gurney, MD
No relevant financial relationship(s) with ineligible companies to disclose
Mark Hamill, MD
No relevant financial relationship(s) with ineligible companies to disclose
Emily Hathaway, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Kimberly M. Hendershot, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Cheralyn J. Hendrix, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Britani R. Hill, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Ashley Hink, MD, MPH
No relevant financial relationship(s) with ineligible companies to disclose
Horacio M. Hojman, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Kyndra Holm, MSN, RN
No relevant financial relationship(s) with ineligible companies to disclose
Roxolana Horbowyj, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Harold Ibagon, MD
No relevant financial relationship(s) with ineligible companies to disclose
Raymond Iezzi, MD, MS
Dr. Iezzi received honorarium from Johnson & Johnson for consultancy
Eliesa A. Ing, MD
No relevant financial relationship(s) with ineligible companies to disclose
David Jacobs, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mubeen Jafri, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Randeep Jawa, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Aaron R. Jensen, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Maria F. Jimenez, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Joey Johnson, MD, FAAOS, FACS
Dr. Johnson received honorarium from Stryker Inc. for consultancy
Laura S. Johnson, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Joakim Jørgensen, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
D’Andrea Joseph, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Catherine Juillard, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Lillian S. Kao, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Krista L. Kaups, MD, MSc, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Katherine Kelley, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
David King, MBBS, FRACS
No relevant financial relationship(s) with ineligible companies to disclose
Denise Klinkner, MD, MEd
No relevant financial relationship(s) with ineligible companies to disclose
Nelly-Ange Kontchou, MD, MBA
No relevant financial relationship(s) with ineligible companies to disclose
Meera Kotagal, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Anastasia Kunac, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Andrew Kurmis, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Sangeeta Lamba, MD, MS-HPEd
No relevant financial relationship(s) with ineligible companies to disclose
Rachel Landisch, MD
No relevant financial relationship(s) with ineligible companies to disclose
Dianne Leverone-Baker, MbChB
No relevant financial relationship(s) with ineligible companies to disclose
Carol A. Lin, MD, FACS
Dr. Lin received payment for consultancy services for Globus medical; payment for speaking engagements for Illuminoss; research grant from Stryker Inc.; payment for speaking engagements for Depuy J&J
Luis E. Llerena, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Sarvesh Logsetty, MD, FRCSC, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Nisreen Maghraby, MBBS, FRCPC(EM)
No relevant financial relationship(s) with ineligible companies to disclose
Muhammad A. Majid, FRCS (Edinburgh), FCPS
No relevant financial relationship(s) with ineligible companies to disclose
Ajai Malhotra, MBBS, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Samuel P. Mandell, MD, FACS
Dr. Mandell received research support at their institution from Polynovo; royalties for authorship from UpToDate
Alicia J. Mangram, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Courtney Mangus, MD
No relevant financial relationship(s) with ineligible companies to disclose
Patrizio Mao, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Katherine Martin, MBBS, BMedSci, FRACS
No relevant financial relationship(s) with ineligible companies to disclose
M. Travis Maynard, PhD
No relevant financial relationship(s) with ineligible companies to disclose
Robert A. Mazzoli, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Joseph McIsaac, MD, MBA
No relevant financial relationship(s) with ineligible companies to disclose
Kathryn McKendy, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Allison McNickle, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Alain Mefire, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Christopher Michetti, MD
No relevant financial relationship(s) with ineligible companies to disclose
David J. Milia, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Anna N. Miller, MD, FACS
Dr. Miller received consultancy fees from Smith and Nephew
Michael Moelmer, Cand.Med
No relevant financial relationship(s) with ineligible companies to disclose
Alexis Moren, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Anne C. Mosenthal, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Angela Muoki, MD, MMed (PRAS)
No relevant financial relationship(s) with ineligible companies to disclose
Bindi Naik-Mathuria, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mayur Narayan, MD, MPH, FACS
No relevant financial relationship(s) with ineligible companies to disclose
John Ng, MD, FACS
Dr. Ng is a stockholder of Bio-Logic Aqua Research Inc.; received research support at their institution from Immunovant; research support at their institution from Horizon/Amgen; research support at their institution from Sling Therapeutics
Peter Nielsen, MD
Dr. Nielsen is a member of Varda5 LLC. He does not receive any compensation for his membership
David M. Notrica, MD, FACS, FAAP
Dr. Nortrica received royalties from KLS; consulting fees from Atricure
Nikiah Nudell, PhD(c), MS, NRP
No relevant financial relationship(s) with ineligible companies to disclose
Kathleen O’Connell, MD, MPH, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Daniel Ojuka, MBBS, FACS
No relevant financial relationship(s) with ineligible companies to disclose
William Oley III, MD, FAAFP
No relevant financial relationship(s) with ineligible companies to disclose
Bryant W. Oliphant, MD, MBA, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Debbie Paltridge, MHSc (Ed), FRACS (Hon)
No relevant financial relationship(s) with ineligible companies to disclose
Neil Parry, MD, FACS
Dr. Parry is a stockholder of Frontline Medical Technologies Inc.
Nirav Patel, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Maria Paulsen, RN, BSN
No relevant financial relationship(s) with ineligible companies to disclose
Ruben Peralta, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Michael Person, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Rodney Petersen, FRANZCOG, MBA
No relevant financial relationship(s) with ineligible companies to disclose
Tam Pham, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Renato Poggetti, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Travis Polk, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Alicia Ponton-Carss, MD, MSc, PhD
No relevant financial relationship(s) with ineligible companies to disclose
Howard Pryor, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Glen Purcell, RN, BSN
No relevant financial relationship(s) with ineligible companies to disclose
Boonkit Purt, MD
No relevant financial relationship(s) with ineligible companies to disclose
Tyler Putnam, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
John Ragheb, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Amulya Rattan, MS (Gen Surg), MCh
No relevant financial relationship(s) with ineligible companies to disclose
Martin Richardson, MBBS, FRACS
No relevant financial relationship(s) with ineligible companies to disclose
Sandro B. Rizoli, MD, PhD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Vicente E. Rodriguez-Maya, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Alan P. Rossi, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mathieu Rousseau, MD
No relevant financial relationship(s) with ineligible companies to disclose
Andres Rousselot, MD
No relevant financial relationship(s) with ineligible companies to disclose
Daniel Rubaclava, MS, MSPH
No relevant financial relationship(s) with ineligible companies to disclose
Andres M. Rubiano, MD, PhD(c)
No relevant financial relationship(s) with ineligible companies to disclose
Rosa Aurora Ruiseco
No relevant financial relationship(s) with ineligible companies to disclose
Babak Sarani, MD, FACS
Dr. Sarani received honorarium for consultancy for Medtronic; honorarium for consultancy for Acumed; honorarium for consultancy for Belmont; honorarium for consultancy for Haemonetics
Thomas J. Schroeppel, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Kevin Schuster, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mark F. Scott, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Mark W. Siboe, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Kristen Sihler, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Dionne A. Skeete, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jesper Skytt-Kjærgaard, RN, M.L.
No relevant financial relationship(s) with ineligible companies to disclose
Tone Slåke, RN
No relevant financial relationship(s) with ineligible companies to disclose
Guy Slater, MBBS, FRCS
No relevant financial relationship(s) with ineligible companies to disclose
Alison Smith, MD, FACS
Dr. Smith received consultancy fees for consultancy for Aroa Biosurgery; advisory board fees for advising for Prytime Medical; research support at their institution from MiMedX; research support at their institution from Dynocardia; research support at their institution from Aroa Biosurgery
Randi N. Smith, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jason A. Snyder, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Søren Steemann Rudolph, MD
No relevant financial relationship(s) with ineligible companies to disclose
Deborah Stein, MD, FACS
Dr. Stein received consultancy fees for consulting for CSL Behring
George Tagkalakis, RN
No relevant financial relationship(s) with ineligible companies to disclose
Gontzal Tamayo, MD, MSc
No relevant financial relationship(s) with ineligible companies to disclose
Leah C. Tatebe, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Errington C. Thompson, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Areti Tillou, MD, MSEd
No relevant financial relationship(s) with ineligible companies to disclose
D Roxanne Todor, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Julio L. Trostchansky, MD, MBA, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Faiz Tuma, MD, MEd, FRCSC
No relevant financial relationship(s) with ineligible companies to disclose
Julie Valenzuela, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Elizabeth Vallejo de Solezio, PhD
No relevant financial relationship(s) with ineligible companies to disclose
Jesus Alberto Varela, MD
No relevant financial relationship(s) with ineligible companies to disclose
Candice Vasconcelos, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Rodrigo Vaz-Ferreira, MD, PhD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Felipe Vega-Rivera, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Vishwajit Verma, FRCA, FFCIM
No relevant financial relationship(s) with ineligible companies to disclose
Derek S. Wakeman, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jarrod Wall, MBBCh, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Jill B. Watras, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Sonlee D. West, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Catherine Wilson, MSN, ACNP-BC
No relevant financial relationship(s) with ineligible companies to disclose
Mark Wilson, PhD, FRCS (SN)
Dr. Wilson is the Medical Director for GoodSAM
Robert J. Winchell, MD, FACS
Dr. Winchell has been provided travel coverage for educational training for Intuitive Corportation
Christoph Woelfel, MD, PhD
No relevant financial relationship(s) with ineligible companies to disclose
Roderick Wouters, MD, FEBS
No relevant financial relationship(s) with ineligible companies to disclose
Michael Wyatt, MD, FRACS (Orth)
No relevant financial relationship(s) with ineligible companies to disclose
Anna Yang, MD
No relevant financial relationship(s) with ineligible companies to disclose
Brad J. Yoo, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose
Ian Young, MD, FRACS
No relevant financial relationship(s) with ineligible companies to disclose
Luis Miguel Zamora-Duarte, MD
No relevant financial relationship(s) with ineligible companies to disclose
Ahmad Zeineddin, MD
No relevant financial relationship(s) with ineligible companies to disclose
At the completion of this course, learners are awarded a Certificate of Completion.
Available Credit
- 0.00 Certificate of Completion
Hardware/Software Requirements
Compatible Browsers
Windows: Google Chrome (latest version), Firefox (latest version), Microsoft Edge (latest version)
Mac: Google Chrome (latest version), Safari (latest version), Firefox (latest version)
Required Browser Settings
Pop-ups: Pop-ups must be enabled on your web browser for you to see the modules after you click on “Launch.”
Javascript: JavaScript must be enabled for published courses to work.
Font Downloads: Font downloads must be enabled to see the correct fonts and characters.
Tablets
Ensure your ringer (or volume) is turned on and not muted or you will not be able to hear the sound when viewing videos or the modules.
The modules are not optimized for viewing on smartphones due to the complexity of the modules.
Additional Software
Adobe Acrobat Reader
Microsoft Office® Word